Call to arrange a consultation
+1 416 777 0888

Bayer Inc. and Bayer Intellectual Property GmbH v Teva Canada Limited

T-1960-18; T-2093-18; T-435-19; T-806-19
Resolved (Interlocutory)
New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,823,159, 2,634,310 and 2,547,113 (rivaroxaban)

Counsel to: 
Sandoz Canada Inc.
here.

Meet the team